Cannabis Law Report

NOVEMBER 11, 2021

F) (the “Company” or “Canntab” ), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers.

Events 52

Events Pharmaceutical Cannabinoids Patients 52

The Cannigma

AUGUST 14, 2023

Sleep is essential for overall health and well-being, and yet, many of us struggle to get a restful night’s sleep. From the daily stressors of life to hormonal changes, various factors can disrupt sleep patterns, especially for perimenopausal women. So, what’s a woman to do? But we’re not completely blind.

Sleep 65

Sleep CBD Cannabinoids THC 65

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. It’s kind of a bridge between THC and CBD.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

JUNE 20, 2023

Pain, anxiety, and sleep are major drivers of medical cannabis use. The endocannabinoid system is widely distributed throughout the gastrointestinal system, including not only CB1 and CB2 cannabinoid receptors but also other cannabinoid targets like PPARs, GPR55, and TRPV1.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

Project CBD

MAY 24, 2023

Ten years ago, most cannabis consumers couldn’t tell a terpene from a cannabinoid. A 2021 study 2 by University of Arizona scientists concluded that certain terpenes are “cannabimimetic” (in a mouse model of cannabis intoxication) and can selectively enhance cannabinoid activity. But today things are different.

Terpenes 274

Terpenes THC Cannabinoids Concentrates 274

United Patients Group

DECEMBER 15, 2023

There is a stubborn stigma surrounding Cannabis and it no longer is simply that Cannabis has no merit or is an entrance drug, but that the non-psychoactive cannabinoid, CBD, is ALL you need for health, wellness, and other ailments which is not totally true. The same goes for using CBD only, we leave out other important cannabinoids.

CBD 119

CBD Terpenes Wellness and Beauty Cannabinoids 119

MMJ Recs

OCTOBER 5, 2023

Maryland Medical Cannabis Strains Medical cannabis strains vary in their cannabinoid profiles and are tailored to address specific symptoms and conditions. In Maryland dispensaries, patients can find a wide selection of strains with different THC (tetrahydrocannabinol) and CBD (cannabidiol) ratios.

Dispensary 52

Dispensary Patients Treatment Conditions 52

The Cannigma

OCTOBER 22, 2023

We need more data on “minor” cannabinoids, on terpenes, on specific cannabinoid ratios and formulations. On hemp-derived and synthetic cannabinoids alike. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types. The list goes on.

Data 88

Data Research and Development Sleep Collective 88

Illinois News Joint

MARCH 11, 2024

Arianne Richards, Executive Director of Chicago NORML, spoke next about what she regarded as, the “troubling mishandling of the petitions submitted in July 2023 to include four women’s health conditions on the list of qualifying conditions for the Medical Cannabis Program.” “Our

Conditions 83

Conditions Advocacy Patients Programs 83

Cannabis Law Report

JUNE 1, 2021

In Beverages, The Company launched a portfolio of THC beverages in the Canadian recreational cannabis market during FY 2021, capturing 35% dollar share of the total beverage category during the full year. Canopy Growth launched Quatreau CBD beverages in Canada in Q3 2021 and captured #1 market share in Canada since launch.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 6, 2021

“We’re continuing to drive cost savings and operational efficiencies across the company, and remain broadly on track to our target of $150 – $200 million in fiscal 2022- fiscal 2023,” added Mike Lee , CFO. “We The Ace Valley Dream gummies contain the CBN minor cannabinoid which lends itself to a key consumer need state, sleep.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed HB 324 , which establishes a regulatory commission to oversee the eventual “production, manufacturing, and dispensing” of products possessing specified quantities of plant-derived THC to qualified patients. The law went into effect on July 1, 2019. The law will take effect on January 1, 2020.

Legislation 59

Legislation Patients Access Banking 59